• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

水蛭素-1对凝血酶的特异性抑制作用及其缓慢裂解

Thrombin-specific inhibition by and slow cleavage of hirulog-1.

作者信息

Witting J I, Bourdon P, Brezniak D V, Maraganore J M, Fenton J W

机构信息

New York State Department of Health, Wadsworth Center for Laboratories and Research, Albany 12201.

出版信息

Biochem J. 1992 May 1;283 ( Pt 3)(Pt 3):737-43. doi: 10.1042/bj2830737.

DOI:10.1042/bj2830737
PMID:1290488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1130947/
Abstract

Hirulog-1 [D-Phe-Pro-Arg-Pro-[Gly]4-desulphohirudin-(53-64) (HV1)] was designed to bind by its first four and last 12 residues to the alpha-thrombin catalytic site and anion-binding exosite for fibrin(ogen) recognition respectively, with a [Gly]4 bridge and an Arg-Pro bond at the scissional position. Human alpha-, gamma- and zeta-thrombins, as well as bovine trypsin, readily hydrolyse Spectrozyme-TH (D-hexahydrotyrosyl-Ala-Arg p-nitroanilide) at pH 7.4 and approx. 23 degrees C. Both alpha- and zeta-thrombins, which have high fibrinogen-clotting activities (greater than 3000 kunits/g), were inhibited with this substrate by hirulog-1 [Ki = 2.56 +/- 0.35 nM (n = 3) and 1.84 +/- 0.15 nM (n = 3) respectively] and slowly cleaved the inhibitor [k = 0.326 +/- 0.082 min-1 (n = 12) and 0.362 +/- 0.056 min-1 (n = 18) respectively], whereas gamma-thrombin, which has essentially no clotting activity (approx. 4 kunits/g), and trypsin were not inhibited with greater than 1000-fold molar excess of hirulog-1. Similar inhibition parameters were also obtained for hirulog-1 incubated with alpha-thrombin or zeta-thrombin at approx. 23 degrees C and by measuring thrombin activity with fibrinogen in the clotting assay at 37 degrees C. Cleavage of the Arg-3-Pro-4 bond in hirulog-1 by either alpha- or zeta-thrombin was shown by identical cleavage products of either thrombin on h.p.l.c. and by sequence analysis of the alpha-thrombin products. These data demonstrate that hirulog-1 is a specific inhibitor of thrombin forms with high fibrinogen-procoagulant activities and that its Arg-3-Pro-4 bond is slowly cleaved by these thrombin forms.

摘要

水蛭素类似物-1 [D-苯丙氨酸-脯氨酸-精氨酸-脯氨酸-[甘氨酸]4-去硫酸水蛭素-(53 - 64) (HV1)] 的设计目的是,其前四个残基和最后12个残基分别与α-凝血酶催化位点和阴离子结合外位点结合,以识别纤维蛋白(原),在裂解位置有一个[甘氨酸]4桥和一个精氨酸-脯氨酸键。人α-、γ-和ζ-凝血酶,以及牛胰蛋白酶,在pH 7.4和约23℃时能快速水解光谱酶-TH(D-六氢酪氨酸-丙氨酸-精氨酸对硝基苯胺)。α-和ζ-凝血酶都具有高纤维蛋白原凝血活性(大于3000库单位/克),水蛭素类似物-1对这种底物能抑制它们 [Ki分别为2.56±0.35纳摩尔(n = 3)和1.84±0.15纳摩尔(n = 3)],并能缓慢裂解抑制剂 [k分别为0.326±0.082分钟-1(n = 12)和0.362±0.056分钟-1(n = 18)],而基本上没有凝血活性(约4库单位/克)的γ-凝血酶和胰蛋白酶,即使使用摩尔过量1000倍以上的水蛭素类似物-1也不会被抑制。在约23℃下,将水蛭素类似物-1与α-凝血酶或ζ-凝血酶一起孵育,并在37℃的凝血试验中用纤维蛋白原测量凝血酶活性,也得到了类似的抑制参数。α-或ζ-凝血酶对水蛭素类似物-1中精氨酸-3-脯氨酸-4键的裂解,通过高效液相色谱法上两种凝血酶相同的裂解产物以及对α-凝血酶产物的序列分析得以显示。这些数据表明,水蛭素类似物-1是具有高纤维蛋白原促凝活性的凝血酶形式的特异性抑制剂,并且其精氨酸-3-脯氨酸-4键会被这些凝血酶形式缓慢裂解。

相似文献

1
Thrombin-specific inhibition by and slow cleavage of hirulog-1.水蛭素-1对凝血酶的特异性抑制作用及其缓慢裂解
Biochem J. 1992 May 1;283 ( Pt 3)(Pt 3):737-43. doi: 10.1042/bj2830737.
2
Inhibition of the amplification reactions of blood coagulation by site-specific inhibitors of alpha-thrombin.α-凝血酶的位点特异性抑制剂对血液凝固扩增反应的抑制作用。
Biochem J. 1992 May 1;283 ( Pt 3)(Pt 3):893-7. doi: 10.1042/bj2830893.
3
Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin.水蛭素类似物的设计与特性:一类新型的凝血酶二价肽抑制剂。
Biochemistry. 1990 Jul 31;29(30):7095-101. doi: 10.1021/bi00482a021.
4
Thrombin specificity with tripeptide chromogenic substrates: comparison of human and bovine thrombins with and without fibrinogen clotting activities.凝血酶与三肽显色底物的特异性:具有和不具有纤维蛋白原凝血活性的人凝血酶和牛凝血酶的比较。
Clin Chem. 1986 Jun;32(6):934-7.
5
Kinetic mechanism for the interaction of Hirulog with thrombin.水蛭素与凝血酶相互作用的动力学机制。
Biochemistry. 1994 Dec 13;33(49):14807-14. doi: 10.1021/bi00253a020.
6
Human alpha- to zeta-thrombin cleavage occurs with neutrophil cathepsin G or chymotrypsin while fibrinogen clotting activity is retained.人α至ζ凝血酶的裂解在中性粒细胞组织蛋白酶G或胰凝乳蛋白酶作用下发生,同时纤维蛋白原的凝血活性得以保留。
Biochemistry. 1990 Apr 10;29(14):3536-42. doi: 10.1021/bi00466a017.
7
Structure of the hirugen and hirulog 1 complexes of alpha-thrombin.α-凝血酶的水蛭素和水蛭素-1复合物的结构
J Mol Biol. 1991 Oct 20;221(4):1379-93.
8
Hirulog peptides with scissile bond replacements resistant to thrombin cleavage.
Biochem Biophys Res Commun. 1991 Jun 28;177(3):1049-55. doi: 10.1016/0006-291x(91)90644-m.
9
The effect of antithrombin III-independent thrombin inhibitors and heparin on fibrin accretion onto fibrin-coated polyethylene.抗凝血酶III非依赖性凝血酶抑制剂和肝素对纤维蛋白在纤维蛋白包被的聚乙烯上沉积的影响。
Thromb Haemost. 1993 Feb 1;69(2):130-4.
10
Hirulog effect in rat endotoxin shock.水蛭素对大鼠内毒素休克的作用
Life Sci. 1995;57(20):PL307-13. doi: 10.1016/0024-3205(95)02170-n.

引用本文的文献

1
Screening of the Promising Direct Thrombin Inhibitors from Haematophagous Organisms. Part I: Recombinant Analogues and Their Antithrombotic Activity In Vitro.从吸血生物中筛选有前景的直接凝血酶抑制剂。第一部分:重组类似物及其体外抗血栓活性
Biomedicines. 2021 Dec 22;10(1):11. doi: 10.3390/biomedicines10010011.
2
Efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitors.新一代基于蜱转录组的直接凝血酶抑制剂的疗效和安全性。
Nat Commun. 2021 Nov 25;12(1):6912. doi: 10.1038/s41467-021-27275-8.
3
Revisiting antithrombotic therapeutics; sculptin, a novel specific, competitive, reversible, scissile and tight binding inhibitor of thrombin.重新审视抗血栓治疗药物;sculptin,一种新型的、特异的、竞争性的、可逆的、可切割的、紧密结合的凝血酶抑制剂。
Sci Rep. 2017 May 3;7(1):1431. doi: 10.1038/s41598-017-01486-w.
4
New Approaches to the Role of Thrombin in Acute Coronary Syndromes: Quo Vadis Bivalirudin, a Direct Thrombin Inhibitor?凝血酶在急性冠状动脉综合征中作用的新研究方法:直接凝血酶抑制剂比伐卢定何去何从?
Molecules. 2016 Feb 27;21(3):284. doi: 10.3390/molecules21030284.
5
A novel stearic acid-modified hirudin peptidomimetic with improved pharmacokinetic properties and anticoagulant activity.一种具有改善的药代动力学性质和抗凝活性的新型硬脂酸修饰水蛭素拟肽。
Sci Rep. 2015 Sep 24;5:14349. doi: 10.1038/srep14349.
6
Bivalirudin as a bridge for anticoagulation in high risk neurosurgical patients with active DVT or high risk of thrombosis.比伐卢定作为一种桥接抗凝药物,用于伴有活动性深静脉血栓或高血栓风险的高危神经外科患者。
Neurocrit Care. 2013 Jun;18(3):349-53. doi: 10.1007/s12028-013-9835-0.
7
Direct thrombin inhibitors in cardiovascular disease.直接凝血酶抑制剂在心血管疾病中的应用。
Nat Rev Cardiol. 2012 May 1;9(7):402-14. doi: 10.1038/nrcardio.2012.61.
8
Crystal structure of thrombin in complex with S-variegin: insights of a novel mechanism of inhibition and design of tunable thrombin inhibitors.凝血酶与 S-变京抑制复合物的晶体结构:新型抑制机制的深入了解和可调式凝血酶抑制剂的设计。
PLoS One. 2011;6(10):e26367. doi: 10.1371/journal.pone.0026367. Epub 2011 Oct 28.
9
New anticoagulants for the prevention and treatment of venous thromboembolism.用于预防和治疗静脉血栓栓塞症的新型抗凝剂。
Vasc Health Risk Manag. 2005;1(1):41-53. doi: 10.2147/vhrm.1.1.41.58936.
10
Management of patients with acute coronary syndromes: what is the clinical role of direct thrombin inhibitors?急性冠状动脉综合征患者的管理:直接凝血酶抑制剂的临床作用是什么?
Drugs. 2002;62(13):1839-52. doi: 10.2165/00003495-200262130-00001.

本文引用的文献

1
Selective immobilization of alpha-thrombin by surface-bound fibrin.表面结合的纤维蛋白对α-凝血酶的选择性固定
J Lab Clin Med. 1981 Mar;97(3):403-11.
2
Thrombin active site regions required for fibroblast receptor binding and initiation of cell division.成纤维细胞受体结合及细胞分裂起始所需的凝血酶活性位点区域。
J Biol Chem. 1980 Jul 25;255(14):6609-16.
3
Thrombin specificity.凝血酶特异性
Ann N Y Acad Sci. 1981;370:468-95. doi: 10.1111/j.1749-6632.1981.tb29757.x.
4
Functional properties of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.一种参与凝血酶催化蛋白C活化的内皮细胞辅因子的功能特性。
J Biol Chem. 1981 Jun 10;256(11):5532-5.
5
Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin.凝血酶催化人纤维蛋白原转化为纤维蛋白的稳态动力学参数。
J Biol Chem. 1983 Aug 10;258(15):9276-82.
6
Protease mitogenic response of chick embryo fibroblasts and receptor binding/processing of human alpha-thrombin.鸡胚成纤维细胞的蛋白酶促有丝分裂反应与人α-凝血酶的受体结合/加工
J Biol Chem. 1981 Mar 25;256(6):2767-76.
7
Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors.紧密结合抑制剂对酶催化反应的可逆抑制动力学。
Biochim Biophys Acta. 1969;185(2):269-86. doi: 10.1016/0005-2744(69)90420-3.
8
Polyethylene glycol 6,000 enhancement of the clotting of fibrinogen solutions in visual and mechanical assays.聚乙二醇6000在视觉和机械检测中对纤维蛋白原溶液凝血的增强作用。
Thromb Res. 1974 Jun;4(6):809-17. doi: 10.1016/0049-3848(74)90024-3.
9
A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors.一个描述酶和亚细胞颗粒与紧密结合抑制剂相互作用的稳态动力学的线性方程。
Biochem J. 1972 Apr;127(2):321-33. doi: 10.1042/bj1270321.
10
Thrombin clotting activity measurement and standardization with lyophilized plasma.凝血酶凝血活性的测定及冻干血浆标准化
Clin Chem. 1986 Feb;32(2):320-4.